Key Takeaways
- • Matt Holt's investment firm Thoreau Group, backed by Apollo Global Management (APO), is in advanced discussions to acquire Ensemble Health Partners in a deal valued at approximately $12 billion, with an agreement potentially imminent.
- • Thoreau Group represents Holt's new venture following his December departure from New Mountain Capital, where he served as president of private equity after joining in 2001.
- • The Ensemble Health acquisition signals Holt's strategic pivot toward healthcare-focused investments through his newly established firm, supported by Apollo Global's capital and resources.
- • This transaction follows the collapse of New Mountain Capital's earlier engagement with Holt over a proposed $32 billion deal, which the firm abandoned by March 2026 citing missed deadlines and a revised bid inferior to the original proposal.
Summary
Matt Holt's newly formed investment firm Thoreau Group is pursuing a major acquisition of Ensemble Health Partners, with negotiations advancing to a stage where deal closure could occur imminently. According to Bloomberg reporting, the transaction is valued at approximately $12 billion, positioning it as a significant healthcare sector transaction in the alternative investment landscape.
Thoreau Group, which counts Apollo Global Management as a key backer, represents Holt's departure from New Mountain Capital, where he had served as president of private equity since 2001. His transition to establish an independent platform in December marked a notable shift in the alternative investment industry, with the new firm focusing on healthcare-related investment opportunities.
The Ensemble Health deal reflects a strategic reorientation for Holt following the termination of negotiations with his former employer. New Mountain Capital had pursued a substantially larger $32 billion transaction with Holt, but abandoned those discussions by March 2026 after Holt missed critical deadlines and submitted a revised offer deemed less favorable than the original proposal. The Ensemble acquisition, while smaller in scale at $12 billion, appears to represent Holt's refocused investment thesis as he establishes Thoreau Group's market presence in the healthcare services sector.
The backing of Apollo Global Management—a major alternative asset manager with substantial capital deployment capabilities—provides Thoreau Group with financial resources and operational infrastructure necessary to close and integrate a transaction of this magnitude in the competitive healthcare services market.
Thoreau Group, which counts Apollo Global Management as a key backer, represents Holt's departure from New Mountain Capital, where he had served as president of private equity since 2001. His transition to establish an independent platform in December marked a notable shift in the alternative investment industry, with the new firm focusing on healthcare-related investment opportunities.
The Ensemble Health deal reflects a strategic reorientation for Holt following the termination of negotiations with his former employer. New Mountain Capital had pursued a substantially larger $32 billion transaction with Holt, but abandoned those discussions by March 2026 after Holt missed critical deadlines and submitted a revised offer deemed less favorable than the original proposal. The Ensemble acquisition, while smaller in scale at $12 billion, appears to represent Holt's refocused investment thesis as he establishes Thoreau Group's market presence in the healthcare services sector.
The backing of Apollo Global Management—a major alternative asset manager with substantial capital deployment capabilities—provides Thoreau Group with financial resources and operational infrastructure necessary to close and integrate a transaction of this magnitude in the competitive healthcare services market.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.